Capstone Investment Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-25,040
Closed -$194K 2038
2025
Q3
$194K Buy
+25,040
New +$195K ﹤0.01% 1842
2024
Q2
Sell
-32,196
Closed -$486K 2463
2024
Q1
$486K Buy
32,196
+29,968
+1,345% +$544K ﹤0.01% 1574
2023
Q4
$48K Sell
2,228
-7,311
-77% -$135K ﹤0.01% 2010
2023
Q3
$177K Buy
+9,539
New +$223K ﹤0.01% 1840
2022
Q4
Sell
-7,777
Closed -$210K 1645
2022
Q3
$197K Buy
7,777
+5,747
+283% +$202K ﹤0.01% 1471
2022
Q2
$67K Buy
+2,030
New +$86.2K ﹤0.01% 1605
2021
Q4
Sell
-13,416
Closed -$1.7M 2081
2021
Q3
$1.7M Hold
13,416
﹤0.01% 1254
2021
Q2
$2.23M Buy
+13,416
New +$2.17M 0.01% 991
2020
Q4
Sell
-98,051
Closed -$21.5M 1760
2020
Q3
$21.5M Buy
+98,051
New +$20.8M 0.11% 159

Other funds holding TDOC

Capstone Investment Advisors's TDOC Position: Q4 2025 in Review

Capstone Investment Advisors sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 25,040 shares — an estimated $194K sold.

Capstone Investment Advisors first reported a position in TDOC in Q3 2020 and held it in 9 quarters. The position peaked at $21.5M in Q3 2020. 344 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • Capstone Investment Advisors reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 25,040 Teladoc Health shares in Q4 2025, an estimated $194K.
  • Capstone Investment Advisors first reported a position in Teladoc Health in Q3 2020 and held it in 9 quarters.
  • Capstone Investment Advisors's Teladoc Health position peaked at $21.5M in Q3 2020.
  • 344 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on Capstone Investment Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.